Atreca, Inc. (BCEL) Financials
BCEL Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 26.3 million | 15.6 million |
2023-06-30 | 115.1 million | 70.4 million |
2023-03-31 | 134.4 million | 73.5 million |
2022-12-31 | 155.0 million | 76.6 million |
BCEL Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -17.3 million | 2.3 million |
2023-06-30 | -18.0 million | 2.9 million |
2023-03-31 | -14.5 million | 3.2 million |
2022-12-31 | -15.6 million | 3.2 million |
BCEL Net Income
No data available :(
BCEL Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 21.4 million | - | 1.3 million |
2023-06-30 | 38.5 million | - | 62.2 million |
2023-03-31 | 56.4 million | - | 63.0 million |
2022-12-31 | 70.5 million | - | 63.9 million |
BCEL Shares Outstanding
BCEL Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 61000 | 10.4 million | 5.4 million | - |
2023-06-30 | 21000 | 12.9 million | 6.8 million | - |
2023-03-31 | 80000 | 13.5 million | 8.1 million | - |
2022-12-31 | 146000 | 13.8 million | 7.5 million | - |
BCEL Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 80000 | 1.4 million |
2023-06-30 | 71000 | 1.7 million |
2023-03-31 | 92000 | 1.7 million |
2022-12-31 | 20000 | 1.8 million |
BCEL
Price: $0.09
52 week price:
Earnings Per Share: -2.50 USD
P/E Ratio: -0.11
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Volume: 154300
Market Capitalization: 3.2 million